After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults. Punam Malik, MD, is the principal investigator.
A daily hydroxyurea pill may bring relief for young children living with sickle cell anemia (SCA) in sub-Saharan Africa, says study in The New England Journal of Medicine led by Russell Ware, MD, PhD.
A new study, led by David Schnadower, MD, and published in The New England Journal of Medicine, shows that a commonly used probiotic is not effective in improving symptoms in young patients with gastroenteritis.
Learn more about the business of science and our expanded Innovation Ventures teams in the Summer 2018 issue of Research Horizons.
Our 2017 Research Annual Report reflects another year of outstanding scientific achievement by our faculty and the Cincinnati Children’s Research Foundation.